Pulse Biosciences PLSE
$45.55 +$1.14 (+2.57%)
Market closed · Nov 20, 8:10 pm ET · Last extended-hours $45.50 -0.11%
Open$44.00
Prev close$44.41
Day range$43.72 – $46.06
Volume466.9K
Market cap$3.35B
P/E (TTM)–
Dividend yield–
Fundamentals
Latest reported quarter: Q3, ended Sep 2026
Revenue$395,000.00+359.3% YoY
Operating profit-$24.29M-19.3% YoY
Net profit-$23.05M-18.9% YoY
Diluted EPS-$0.32-10.3% YoY
Free cash flow-$15.42M-17.7% YoY
Operating cash flow-$15.27M
Revenue, last 8 quarters
Net profit, last 8 quarters
Diluted EPS by quarter
Free cash flow by quarter
Annual revenue
Profitability & balance sheet
Gross margin26.8%
Operating margin-5,821.1%
Net margin-5,603.9%
Return on equity-60.6%
Return on assets-54.0%
Return on invested capital-59.9%
Current ratio14.35
Liabilities / assets8.9%
Cash & investments$189.19M
Total debt$4.62M
Net cash (debt)$184.58M
Income statement
| Line item | 2026 Q3 | 2026 Q2 | 2026 Q1 | 2025 ANNUAL | 2025 Q4 |
|---|---|---|---|---|---|
| Total Revenue as Reported | $395,000.00 | $434,000.00 | $401,000.00 | $350,000.00 | $264,000.00 |
| Total Operating Revenue | $395,000.00 | $434,000.00 | $401,000.00 | $350,000.00 | $264,000.00 |
| Cost of Revenue | $191,000.00 | $273,000.00 | $370,000.00 | $539,000.00 | $260,000.00 |
| Gross Profit | $204,000.00 | $161,000.00 | $31,000.00 | -$189,000.00 | $4,000.00 |
| Operating Expense | $24.50M | $25.43M | $19.18M | $76.75M | $18.26M |
| Selling and Admin Expenses | $7.65M | $8.46M | $6.59M | $32.03M | $7.33M |
| Research & Development | $16.85M | $16.98M | $12.59M | $44.72M | $10.93M |
| Operating Profit | -$24.29M | -$25.27M | -$19.15M | -$76.94M | -$18.25M |
| Net Non-Operating Interest Income (Expense) | $1.21M | $600,000.00 | $593,000.00 | $4.21M | $825,000.00 |
| Non-Operating Interest Income | $1.21M | $600,000.00 | $593,000.00 | $4.21M | $825,000.00 |
| Other Income (Expense) | $36,000.00 | $15,000.00 | -$24,000.00 | -$52,000.00 | -$5,000.00 |
| Other Non-Operating Income (Expenses) | $36,000.00 | $15,000.00 | -$24,000.00 | -$52,000.00 | -$5,000.00 |
| Pretax Profit | -$23.05M | -$24.66M | -$18.58M | -$72.78M | -$17.43M |
| Net Profit | -$23.05M | -$24.66M | -$18.58M | -$72.78M | -$17.43M |
| Profit from Continuing Operations | -$23.05M | -$24.66M | -$18.58M | -$72.78M | -$17.43M |
| Net Income to Parent Company | -$23.05M | -$24.66M | -$18.58M | -$72.78M | -$17.43M |
| Net Income to Common Stockholders | -$23.05M | -$24.66M | -$18.58M | -$72.78M | -$17.43M |
| Basic EPS | -$0.32 | -$0.36 | -$0.27 | -$1.08 | -$0.26 |
| Diluted EPS | -$0.32 | -$0.36 | -$0.27 | -$1.08 | -$0.26 |
| -General & Admin Expense | – | $8.46M | – | – | – |
Balance sheet
| Line item | 2026 Q3 | 2026 Q2 | 2026 Q1 | 2025 ANNUAL | 2025 Q4 |
|---|---|---|---|---|---|
| Total Assets | $201.58M | $115.56M | $81.62M | $94.54M | $94.54M |
| Total Current Assets | $192.21M | $105.70M | $71.13M | $83.42M | $83.42M |
| Cash and Cash Equivalents & Short-Term Investments | $189.19M | $101.62M | $68.32M | $80.74M | $80.74M |
| -Cash and Cash Equivalents | $36.73M | $101.62M | $68.32M | $80.74M | $80.74M |
| -Short Term Investments | $152.47M | – | – | – | – |
| Receivables | $297,000.00 | $122,000.00 | $157,000.00 | $274,000.00 | $274,000.00 |
| -Accounts Receivable | $297,000.00 | $122,000.00 | $157,000.00 | $274,000.00 | $274,000.00 |
| Inventory | $232,000.00 | $236,000.00 | $206,000.00 | $136,000.00 | $136,000.00 |
| Other Current Assets | $2.49M | $3.72M | $2.45M | $2.28M | $2.28M |
| Total Non-Current Assets | $9.38M | $9.86M | $10.49M | $11.12M | $11.12M |
| Net PPE | $6.13M | $6.45M | $6.72M | $7.06M | $7.06M |
| -Gross PPE | $6.13M | $6.45M | $6.72M | $11.44M | $11.44M |
| Goodwill and Other Intangible Assets | $2.85M | $3.01M | $3.20M | $3.37M | $3.37M |
| -Goodwill | $2.79M | $2.79M | $2.79M | $2.79M | $2.79M |
| -Other Intangible Assets | $55,000.00 | $222,000.00 | $408,000.00 | $575,000.00 | $575,000.00 |
| Other Non-Current Assets | $398,000.00 | $403,000.00 | $575,000.00 | $691,000.00 | $691,000.00 |
| Total Liabilities | $18.01M | $16.06M | $15.32M | $13.88M | $13.88M |
| Total Current Liabilities | $13.40M | $10.98M | $9.80M | $7.92M | $7.92M |
| Payables | $3.02M | $2.83M | $2.76M | $2.78M | $2.78M |
| -Accounts Payable | $3.02M | $2.83M | $2.76M | $2.78M | $2.78M |
| Current Accrued Expenses | $4.24M | $2.56M | $2.12M | $1.60M | $1.60M |
| Short-Term Debt and Capital Lease Obligation | $1.75M | $1.69M | $1.63M | $1.57M | $1.57M |
| -Current Capital Lease Obligation | $1.75M | $1.69M | $1.63M | $1.57M | $1.57M |
| Total Non-Current Liabilities | $4.62M | $5.09M | $5.53M | $5.96M | $5.96M |
| Long Term Debt and Capital Lease Obligation | $4.62M | $5.09M | $5.53M | $5.96M | $5.96M |
| -Long Term Capital Lease Obligation | $4.62M | $5.09M | $5.53M | $5.96M | $5.96M |
| Total Equity | $183.57M | $99.50M | $66.30M | $80.66M | $80.66M |
| Stockholders' Equity | $183.57M | $99.50M | $66.30M | $80.66M | $80.66M |
| Capital Stock | $73,000.00 | $71,000.00 | $68,000.00 | $68,000.00 | $68,000.00 |
| -Common Stock | $73,000.00 | $71,000.00 | $68,000.00 | $68,000.00 | $68,000.00 |
| -Preferred Stock | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Additional Paid-In Capital | $713.15M | $605.95M | $548.09M | $543.87M | $543.87M |
| Retained Earnings | -$529.57M | -$506.52M | -$481.86M | -$463.28M | -$463.28M |
| Gains/Losses Not Affecting Retained Earnings | -$83,000.00 | – | – | – | – |
| -Accumulated Depreciation | – | – | – | -$4.37M | -$4.37M |
Cash flow
| Line item | 2026 Q3 | 2026 Q2 | 2026 Q1 | 2025 ANNUAL | 2025 Q4 |
|---|---|---|---|---|---|
| Operating Cash Flow | -$15.27M | -$18.71M | -$14.60M | -$54.12M | -$14.76M |
| Net cash flow from continuing operations | -$15.27M | -$18.71M | -$14.60M | -$54.12M | -$14.76M |
| Net Income from Continuing Operations | -$23.05M | -$24.66M | -$18.58M | -$72.78M | -$17.43M |
| Depreciation & Depletion & Amortization | $261,000.00 | $254,000.00 | $255,000.00 | $1.07M | $259,000.00 |
| Other Non-Cash Items | $553,000.00 | $329,000.00 | $370,000.00 | $1.15M | $306,000.00 |
| Change in Working Capital | $2.14M | $392,000.00 | $1.17M | -$5.02M | -$2.86M |
| -Change in Receivables | -$121,000.00 | $43,000.00 | $55,000.00 | -$274,000.00 | -$259,000.00 |
| -Change in Inventory | $4,000.00 | -$30,000.00 | -$70,000.00 | -$136,000.00 | -$79,000.00 |
| -Change in Prepaid Assets | $346,000.00 | -$433,000.00 | -$129,000.00 | -$912,000.00 | -$360,000.00 |
| -Change in Payables and Accrued Expense | $2.31M | $1.19M | $1.68M | -$2.32M | -$1.81M |
| -Change in Other Current Assets | $5,000.00 | $4,000.00 | $3,000.00 | -$14,000.00 | $14,000.00 |
| -Change in Other Current Liabilities | -$409,000.00 | -$383,000.00 | -$375,000.00 | -$1.37M | -$360,000.00 |
| Net cash flow from investing | -$152.49M | -$90,000.00 | -$33,000.00 | -$335,000.00 | -$105,000.00 |
| Net Cash Flow from Continuing Investing Activities | -$152.49M | -$90,000.00 | -$33,000.00 | -$335,000.00 | -$105,000.00 |
| Net PPE Purchase and Sale | -$142,000.00 | -$90,000.00 | -$33,000.00 | -$315,000.00 | -$105,000.00 |
| Net Intangibles Purchase and Sale | $0.00 | – | – | -$20,000.00 | $0.00 |
| Financing Cash Flow | $102.87M | $52.10M | $2.21M | $17.15M | $381,000.00 |
| Net Cash Flow from Continuing Financing Activities | $102.87M | $52.10M | $2.21M | $17.15M | $381,000.00 |
| Net Common Stock Issuance | $96.35M | $45.93M | $465,000.00 | $0.00 | $0.00 |
| Proceeds from Stock Option Exercised | $6.52M | $6.12M | $1.80M | $17.15M | $381,000.00 |
| Ending Cash Balance | $36.73M | $101.62M | $68.32M | $80.74M | $80.74M |
| Net Change in Cash | -$64.90M | $33.30M | -$12.42M | -$37.30M | -$14.48M |
| Beginning Cash Balance | $101.62M | $68.32M | $80.74M | $118.04M | $95.21M |
| Free Cash Flow | -$15.42M | -$18.80M | -$14.63M | -$54.46M | -$14.86M |
| Net Other Financing Charges | – | – | -$57,000.00 | – | – |
No comments yet — be the first to weigh in on PLSE.
Sign in to join the discussion.